Form 4: Rocket Lab Director Matthew Ocko Sells Over 1 Million Shares in Pre-Planned Transactions

Rocket Lab Corporation Director Matthew Ocko executed sales of over 1 million shares of common stock across two days in June 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Matthew Ocko, a Director of Rocket Lab Corporation (RKLB), reported the sale of common stock.
• On June 12, 2025, Mr. Ocko sold a total of 200,000 shares of common stock at a weighted average price of $26.4437 per share.
• These sales included 57,822 shares held directly and 142,178 shares held indirectly through DCVC Opportunity Fund II, L.P.
• On June 13, 2025, an additional 820,000 shares of common stock were sold at a weighted average price of $26.0067 per share.
• These sales included 237,068 shares held directly and 582,932 shares held indirectly through DCVC Opportunity Fund II, L.P.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following these transactions, Mr. Ocko's beneficial ownership includes 1,320,121 shares held indirectly through Data Collective IV, L.P. and 3,246,071 shares held indirectly through DCVC Opportunity Fund II, L.P. as of June 12, 2025.
• Following the June 13, 2025 transactions, beneficial ownership includes 1,083,053 shares held indirectly through Data Collective IV, L.P. and 2,663,139 shares held indirectly through DCVC Opportunity Fund II, L.P.
• Mr. Ocko disclaims beneficial ownership of these securities except to the extent of his indirect pecuniary interest therein.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the significant volume of shares sold by a director. While the sales were conducted under a Rule 10b5-1 plan, which indicates they were pre-scheduled and not necessarily a reaction to new negative information, large insider sales can still be perceived as a lack of confidence or a move to diversify holdings, potentially impacting investor sentiment.

Negatives

• The sale of over 1 million shares by a director, even if pre-planned, could be perceived negatively by investors as it represents a significant reduction in insider holdings.
• The sales occurred at relatively high prices, which might suggest the director is taking profits.

Risks

• Investor perception risk: Significant insider selling, even under a 10b5-1 plan, can sometimes lead to negative market sentiment or speculation about the company's future prospects.
• Liquidity risk for the director: The sales represent a diversification or liquidity event for the director, but do not inherently pose a direct risk to the company's operations.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is an insider transaction report and does not provide direct information about broader industry trends or competitors. However, insider selling can sometimes be interpreted in the context of the overall market and industry sentiment, though these specific sales were pre-planned.

Stakeholder Impact

• Shareholders: May view the significant insider selling as a negative signal, potentially leading to a decrease in share price or a reassessment of the company's prospects, despite the pre-planned nature of the sales.

Key Dates

Keywords

Rocket Lab, RKLB, Insider Sale, Form 4, Matthew Ocko, Director, Stock Transaction, 10b5-1 Plan, Beneficial Ownership